Infectious Disease Research
Featured Clinical Trials
Meet the Team
To aid operations in the containment, mitigation, surge, and post-surge phases of the pandemic, AdventHealth developed the COVID-19 Pandemic Tracker, where all orders for COVID-19 tests and their results are curated in a big data server, allowing for near real-time reporting. AdventHealth collects data resulting from nasopharyngeal and saliva PCR testing, serology, and rapid antigen testing in our inpatient, outpatient, and ED facilities. COVID-19 testing volumes, positive patient census, and intervention utilization and outcomes are published every half hour on the Pandemic Tracker Microsoft PowerBI dashboard. Supplementary dashboards track COVID-19 patient demographic and clinical data, cohort unit capacity, lab turnaround times, supply chain, PPE and medication inventory and demand.
The AdventHealth Research Institute initiated a registry study in order to collect and disseminate clinical and laboratory data for research for all patients tested in the Central Florida Division. Soon to be expanded to the entire AdventHealth enterprise, the registry was developed under the IRB approved protocol named “Registry and Biorepository of COVID-19 for AdventHealth Enterprise” (RECOVER-19 - AdventHealth IRBNet # 1590483). This protocol can support feasibility queries and is approved for data collection for the next five years.
RECOVER-19 is a real-world data (RWD) registry that includes clinical data on all patients tested for Coronavirus Disease 2019 (COVID-19) (both positive and negative) at AdventHealth CFD beginning January 1, 2020. The registry includes zip codes; demographic information; all personal medical history; and COVID-19 encounter clinical information such as type of encounter, length of stay, presenting symptoms, outcome, medication history during all inpatient visits and post-discharge, all procedures and diagnoses, and approximately 80 selected labs.